Organization (Academic)
Udayana University
ClinicalTrials.gov lists Udayana University as lead sponsor of 32 trials. It has 10 active development programs and 9 approved assets.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 3 registered with a 2026 start date. The dashed outline is the pace from the 3 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 4.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Logo Wikimedia Commons contributors, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.
This page covers Udayana University: 32 lead-sponsored trials and 1 legal-entity registration.
Disease areas (32)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Pain | 11 |
| Postoperative Pain | 10 |
| Acquired Immunodeficiency Syndrome | 2 |
| Acute Pain | 2 |
| COVID-19 | 2 |
Showing 5 of 32 disease areas.
Trials by start year as sponsor or collaborator (12)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2025 | 5 |
| 2024 | 7 |
| 2023 | 2 |
| 2022 | 3 |
| 2021 | 6 |
| 2020 | 5 |
| 2018 | 1 |
| 2017 | 1 |
| 2016 | 1 |
Showing 10 of 12 years.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Active development programs (10)
Shown in this order: max phase, then active trials.
| Drug | Disease area | Max phase | Trials |
|---|---|---|---|
| Ultrasound guided Rectus sheath block | Pain | Not reported | 1 |
| Ultrasound guided Rectus sheath block | Postoperative Pain | Not reported | 1 |
| Bupivacain | Head and Neck Neoplasms | Not reported | 1 |
| Bupivacain | Hyperthyroidism | Not reported | 1 |
| Bupivacain | Thyroid Neoplasms | Not reported | 1 |
Showing 5 of 10 active programs.
Approved assets (9)
Shown in this order: max phase first.
| Drug | Trials |
|---|---|
| General Anesthesia | 2 |
| Bupivacain | 2 |
| Dexmedetomidine & Bupivacaine. | 2 |
| DEXMEDETOMIDINE | 1 |
| Nebulized Dexmedetomidine for Post-Anesthesia Delirium in Preschool Children | 1 |
Showing 5 of 9 approved assets.
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 89% hit target (n=9) | 70% on time (n=10) |
Journals published in (81)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Journal of travel medicine | 10 |
| The New England journal of medicine | 6 |
| Travel medicine and infectious disease | 6 |
| Current opinion in HIV and AIDS | 4 |
| Journal of acquired immune deficiency syndromes (1999) | 4 |
Showing 5 of 81 journals.
Organization relationships (6)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Universitas Gadjah Mada | Co sponsors trial with | 2 |
| Sardjito Hospital Yogyakarta | Co sponsors trial with | 2 |
| Universitas Katholik Atmajaya | Co sponsors trial with | 2 |
| Department of Foreign Affairs and Trade (DFAT), Australia | Co sponsors trial with | 1 |
| Yayasan Kerti Praja | Co sponsors trial with | 1 |
Showing 5 of 6 relationships.
Latest dated events (36)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-07-30 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-04-16 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-04-10 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-09-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-08-21 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 36 events.
Biomarkers this organization publishes on (25)
Shown in this order: most publications first.
Showing 5 of 25 biomarkers.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarker capability evidence.